Introduction
Ubiquitination plays an important role in many basic cellular processes, including cell cycle progression, transcriptional control, protein sorting, and immune response. Ubiquitination is controlled by a multienzyme cascade that involves E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitinprotein ligase) activities. E3 recruits substrates to the ubiquitin machinery and specifies which proteins are targeted for degradation (Weissman, 2001) .
The v-src oncogene, the transforming gene of Rous sarcoma virus, encodes a constitutively activated form of c-Src. c-Src is a nonreceptor-type protein tyrosine kinase that is important for various mitogenic signalings and has been implicated in a variety of cancers. v-Src activates a number of signaling proteins and leads to transformation (Bjorge et al., 2000) . Constitutive activation of signal transducers and activators of transcription 3 (STAT3), phosphatidylinositol 3-kinase (PI3-K)/Akt, and Ras/mitogen-activated protein kinase (MAPK) was observed in v-Src-transformed cells (Odajima et al., 2000) .
The c-cbl was identified as a cellular homologue of vcbl, a part of the transforming gene of the Cas-NS-1 retrovirus. Introduction of Cas-NS-1 retrovirus induced the formation of pre-and pro-B lymphomas in mice (Langdon et al., 1989) . c-Cbl (called Cbl here after) and two other Cbl homologues, Cbl-b and Cbl-c/Cbl-3 (Cblc hereafter), have been identified in vertebrates, as have invertebrate orthologues in Drosophila melanogaster (DCbl) and Caenorhabditis elegans (Sli-1). All Cbl family members share a highly conserved tyrosine-kinase binding (TKB) domain and a RING finger. The sequence homology is less extensive in the carboxy-terminal regions of Cbl family proteins .
The TKB domain of Cbl recognizes activated tyrosine kinases such as epidermal growth factor receptor (EGFR), platelet-derived growth factor receptor (PDGFR), and Syk ). The RING finger domain was recently shown to recruit the E2 ubiquitin-conjugating protein and function as an E3 ubiquitin ligase (Joazeiro et al., 1999) . The studies suggest that Cbl recognizes autophosphorylated tyrosine kinases through its TKB domain and degrades them via its E3 activity.
Although Cbl regulates tyrosine kinases negatively by acting as a ubiquitin ligase, Cbl family proteins can also function as adaptor proteins in tyrosine kinase signaling. For example, Cbl promotes integrin-mediated PI3-K activation (Meng and Lowell, 1998) . Cbl-b positively regulates PLCg2 activation by Btk (Yasuda et al., 2002) . Thus, it is important to address the roles of Cbl proteins with respect to the signaling pathways in which they are involved.
Cbl-deficient mice show hyperplastic changes in mammary and lymphoid tissues (Murphy et al., 1998) . In contrast, Cbl-b-deficient mice are highly susceptible to autoimmune disease, indicating that Cbl and Cbl-b have distinct roles Chiang et al., 2000) . However, the restricted phenotypes of cbl-and cbl-b-deficient mice also suggest that there is functional redundancy among Cbl family members. Determining the target proteins of each Cbl protein will be key to understanding the functions of these proteins.
Previously, we reported that expression of Cbl-c is high in colon and small intestine, and this pattern is different from those of Cbl and Cbl-b (Kim et al., 1999) . Elevated levels of Src protein and/or kinase activity have been reported in many colon carcinomas (Irby and Yeatman, 2000) . Thus, the ligase responsible for Src ubiquitination may be a potential tumor suppressor. In the present study, we examined the roles of Cbl-c, Cbl, and Cbl-b in the regulation of Src.
Materials and methods

Cell culture assay
Human embryonic kidney 293T cells and PlateE cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum. v-Src-transformed NIH3T3 cells and c-SrcY530F stably expressing NIH3T3 cells were maintained in DMEM containing 10% bovine serum. Retroviral expression of Cbl family proteins and colony formation assay were performed as described previously (Suzuki et al., 2002) . To determine the growth rate of the cells, 1.5 Â 10 5 cells were plated on 6-mm dishes, and triplicate dishes were harvested at daily intervals for counting the number of the cells.
Antibodies and reagents
Anti-FLAG mAb (M2) was purchased from Sigma. Antiinfluenza hemaglutinin (HA) mAb (12CA5) and anti-green fluorescent protein (GFP) were from Roche Molecular Biochemicals. Streptavidin conjugated to horseradish peroxidase (HRP) was from Amersham Biosciences. Anti-phosphotyrosine mAb (RC-20) was from Transduction Laboratories. Anti-Src (327) and anti-a-tubulin mAb were from Oncogene Science. Anti-Cbl-c polyclonal antibody has been previously described (Kim et al., 1999) . Antiphospho-Src (pTyr416) and anti-nonphospho-Src (Tyr416) mAb were from Cell Signaling. Synthetic peptides with the following sequences in human cSrc (CLIEDNEpYTARQR and CLIEDNEYTARQR) were supplied by Dr Ohmi (University of Tokyo).
DNA constructions
For the retroviral expression of Cbl family proteins, the fulllength human HA-Cbl cDNA (a gift of Dr Longdon), HACbl-b cDNA (a gift of Dr Lipkowitz), and human Cbl-c cDNA were subcloned into the pMX puro expression vector (a gift of Dr Kitamura). Mutation of Gly276 to Glu, Cys351 to Ala, and deletion of Tyr341 designated DY341 were introduced into the human Cbl-c cDNA by site-directed mutagenesis. The human Cbl-c sequence encoding amino-acid residues 1-350, designated TKB, was generated by BglII-mediated deletion. These cDNAs were then cloned into pME18S-FLAG or its derivative, pME18-GST. For production of bacuroviral GST-Src protein, cDNAs for Src and SrcK298M were cloned into the pFastBAC-GST. The E2 s cDNAs were subcloned into the pGEX6P-1 vector. pGEX4T-1-UbcH7 is a kind gift of Dr Yokouchi.
Protein analysis
Transient cell transfection, immunoprecipitation, and immunoblotting were performed as described . For the proteasomal and lysosomal inhibitor experiments, cells were incubated with 40 mM MG132 (Peptide Inst.), 10 mM lactacystin (Peptide Inst.), 10 mM methylamine (Sigma), 20 nM bafilomycine (Sigma), or 100 mM chloroquine (Sigma) at 371C for 4 h before harvest. To detect ubiquitinated Src in 293T cells, His-ubiquitin conjugated Src was purified as described (Rousseau et al., 1999) .
In vitro binding assay
Purification of GST-Src (WT or K298M) and in vitro kinase reaction were performed as described (Nakazawa et al., 2001) . 293T cells that express FLAG-Cbl-c WT or mutants were lysed in TNE buffer and the cleared lysates were incubated with in vitro phosphorylated GST-Src (1 mg) at 41C for 4 h. For peptide-inhibition experiments, a synthetic phospho-or nonphosphorylated peptide that was derived from Src was added during incubation.
In vitro ubiquitination assay GST-E2 proteins were expressed in BL21(DE3) and purified by glutathione-sepharose 4B, and the GST was removed with PreScissiont protease (Amersham). As E3 proteins, GST-Cbl family proteins were expressed in 293T cells and purified. GSTSrc was purified and the GST was removed. The in vitro ubiquitination assay was performed as described (Honda and Yasuda, 1999) .
Results
Cbl proteins suppress anchorage-independent growth of v-Src-transformed NIH3T3 cells
We examined the suppression of v-Src-induced transformation by Cbl proteins, with a retrovirus-mediated expression system that permits the low-level expression of the exogenous protein. We constructed retroviruses encoding mock, wild-type Cbl, wild-type Cbl-b, wildtype Cbl-c, a TKB mutant of Cbl-c (Gly276 to Glu, Cblc G276E), and a RING finger mutant of Cbl-c (Cys351 to Ala, Cbl-c C351A). We infected v-Src-transformed NIH3T3 cells with retroviruses, selected infected cells with puromycin, and then examined anchorage-independent growth of the cells. As shown in Figure 1 , expression of all the three wild-type Cbl family proteins suppressed v-Src-induced transformation. In contrast, anchorage-independent growth of v-Src-transformed cells was only partially inhibited by Cbl-c C351A and was not affected by Cbl-c G276E. Therefore, the TKB domain and RING finger of Cbl-c appear to be important for antioncogenic activity against v-Src.
Ras-transformed NIH3T3 cells were not affected by retroviruses encoding wild-type Cbl family proteins, indicating that the antioncogenic activities of these viruses are cell-type specific (data not shown). The growth rates of v-Src transformed cells infected with these retroviruses were indistinguishable (Figure 1b ).
Cbl-c specifically reduces the levels of v-Src protein and causes reversion of the morphology of v-Src-transformed cells
Another phenotype of transformed cells, refractile morphology, was examined by phase-contrast microscopy. In contrast to the anchorage-independent growth assay, expression of wild-type Cbl-c, but not Cbl, Cbl-b, and Cbl-c mutants, reverted the morphology of v-Srctransformed NIH3T3 cells (Figure 2A ). The data suggest that the mechanism of suppression of v-Srcmediated transformation by Cbl-c differs from that by Cbl and Cbl-b.
To address the molecular mechanism by which Cbl-c inhibits v-Src-mediated transformation, we first examined the level of v-Src protein in retrovirus-infected cells. The level of v-Src protein was reduced significantly by expression of wild-type Cbl-c, whereas it was not affected significantly by expression of Cbl, Cbl-b, or Cbl-c mutants ( Figure 2B Degradation of ubiquitinated proteins is mediated by proteasome and lysosomes (Lee et al., 1999) . We established an NIH3T3 clone that expresses SrcY530F, an active form of Src. The level of Src in these cells that were infected with the retroviruses was examined in the presence of lysosome inhibitors (methylamine, bafilomycin, and chloroquine) or proteasome inhibitors (MG132 and lactacystin). Cbl-c-mediated degradation of Src was inhibited by lysosome inhibitors but not proteasome inhibitors ( Figure 2C, upper panel) . Degradation of v-Src by Cbl-c was also inhibited by these lysosome inhibitors (data not shown). These results suggest that Cbl-c degraded v-Src and activated Src through lysosomes.
Cbl-c binds through its TKB domain to Src phosphorylated at Tyr419
A TKB domain mutant, Cbl-c G276E, did not induce degradation of v-Src, suggesting that the phosphorylation-dependent interaction between Cbl-c and Src is critical in degradation of Src. To examine whether Cbl-c interacts with Src directly, 293T cells were transfected with plasmids expressing wild-type Cbl-c, Cbl-c G276E, Cbl-c C351A, Cbl-c TKB, in which the RING finger and a proline-rich region were deleted, and Cbl-c TKB with G276E mutation ( Figure 3A) . GST-Src fusion protein was expressed by a baculovirus system, purified, and phosphorylated in vitro in the presence or absence of ATP. In vitro phosphorylated GST-Src was incubated with lysates of transfected 293T cells, and the amounts of Cbl-c bound to GST-Src were examined ( Figure 3B ). Wild-type Cbl-c and Cbl-c C351A bound to Src, and this binding was enhanced by phosphorylation of Src. Cbl-c G276E bound slightly to Src, and this binding was independent of Src phosphorylation. Cbl-c TKB bound Src, but this binding was slightly lower than that of wildtype Cbl-c. Furthermore, Cbl-c TKB with G276E mutation did not bind to phosphorylated Src (Figure (Kim et al., 1999) . These data suggest that Cbl-c binds to phosphorylated Src primarily through the TKB domain. A phosphorylation-independent interaction between the SH3 domain of Src and a proline-rich region of Cbl-c may be involved in the binding of Src and Cbl-c. Tyr419 and Tyr530 of human Src (Tyr416 and Tyr527 of chicken Src, respectively) are major phosphorylation sites of Src (Bjorge et al., 2000) . Tyr419 is highly conserved among Src family members, and the flanking amino-acid sequence confirms to the consensus Cbl docking site (D (D/N) xpYxxxP) (Lupher et al., 1997) . To examine if phosphorylation of Src at Tyr419 contributes to binding of Cbl-c with Src, we synthesized tyrosine-phosphorylated and nonphosphorylated peptides that correspond to amino acids 413-424 of Src. As shown in Figure 3C , the phosphopeptide, whereas the nonphosphorylated form did not, inhibited in vitro binding between Src and Cbl-c in a dose-dependent manner. These data show that Cbl-c binds to Src, through an interaction between the autophosphorylated Tyr419 of Src and the TKB domain of Cbl-c.
3B-a, lane 5). Previously, we reported that Cbl-c interacts with the SH3 domain of Fyn in vitro
Cbl-c promotes ubiquitination of activated Src in vivo
The level of v-Src was decreased by Cbl-c ( Figure 2B ), suggesting that Cbl-c acts as a ubiquitin ligase for Src. To study the ubiquitination of Src by Cbl-c, we expressed a combination of wild-type Src, Cbl-c, and histidine epitope-tagged ubiquitin (His-Ub) in 293T cells. Proteins conjugated with His-ubiquitin were purified under denaturing conditions. High molecular weight protein bands for Src, which corresponded to ubiquitinated forms of Src, were observed when wildtype Cbl-c and His-Ub were expressed ( Figure 4A-a) . vSrc was also ubiquitinated in the presence of Cbl-c ( Figure 4B-a) . In contrast, a RING finger mutant, Cbl-c C351A, did not promote ubiquitination of Src. These findings indicate that Cbl-c acts as a RING-type ubiquitin ligase for Src in vivo. Src was only weakly ubiquitinated by Cbl-c G276E, suggesting that the binding of Cbl-c with Src through its TKB domain is important for ubiquitination of Src ( Figure 4A-a) .
Moreover, we examined whether Cbl and Cbl-b act as ubiquitin ligases for Src. Coexpression of Cbl and Cbl-b with Src and His-Ub in 293T cells promoted ubiquitination of Src ( Figure 4C-a) . However, comparison of the level of ubiquitinated Src signal revealed that Cbl-c has the highest ubiquitin ligase activity among Cbl family proteins ( Figure 4C-a, lanes 10, 12, and 14) . Levels of exogenous proteins were confirmed by immunoblotting ( Figure 4A-b, B-b, and C-b) . Levels of Cbl-family proteins were decreased by coexpression of Src (see below).
Cbl-c functions as an E3 ubiquitin ligase for Src in vitro
To further understand the mechanism of Src ubiquitination by Cbl-c, we used an in vitro ubiquitination assay with recombinant proteins. To date, more than 13 E2 ubiquitin-conjugating enzymes have been identified (Weissman, 2001) . To reconstitute the ubiquitination system in vitro, we first searched for E2(s) that cooperate with Cbl-c. The in vitro ubiquitination reaction was carried out in the presence of E1, ATP, biotinylated Ub, 293T-derived GST-Cbl-c, and E2 proteins. Ubiquitinated proteins were detected with extra-avidin peroxidase. Of nine recombinant E2s tested, selfubiquitination of Cbl-c was detected in the presence of E2s UbcH4, UbcH5A, UbcH5B, and UbcH5C, indicating that these E2s are coupled functionally with Cbl-c ( Figure 5A ). Other E2s, including UbcH7, were not active in this assay. We used UbcH5C in our in vitro ubiquitination assay. Wild-type (WT) and kinase inactive (K298M) GST-Src were purified, and the GST removed with PreScissiont protease. The in vitro ubiquitination assay contained E1, E2 (UbcH5C), E3 (GST-Cbl-c), substrate (WT or K298M Src), ATP, and biotinylated Ub. Each reaction mixture was then subjected to immunoblotting with anti-Src antibody ( Figure 5B-a) . WT Src, but not K298M Src, was ubiquitinated by Cbl-c in vitro ( Figure 5B -a, lanes 6 and 7). Similar patterns of high molecular weight protein bands were detected with both anti-Src and extra-avidin peroxidase confirming that these signals corresponded to ubiquitinated Src ( Figure 5B-a and -d) .
We used phosphorylation state-specific antibodies against Tyr419 of Src, to examine whether ubiquitination of Src requires phosphorylation of Tyr419. As shown in Figures 5B and C , ubiquitinated forms of Src were detected with anti-phospho-Src but not antinonphospho-Src, suggesting that Cbl-c specifically promotes ubiquitination of Tyr419 autophosphorylated Src.
Src activates RING-dependent ubiquitin ligase activity of Cbl-c
The structural features of Cbl-c necessary for ubiquitin ligase activity were examined by in vitro test of a series of GST-Cbl-c proteins. It was reported that the RING finger and Tyr371 of Cbl were important for E3 ligase activity (Levkowitz et al., 1999; . Ubiquitination of Src by Cbl-c was abolished by the C351A mutation in the RING finger, indicating that the ubiquitin ligase activity of Cbl-c is RING finger dependent in vitro ( Figure 6A, lane 7) . We found that self-ubiquitination of Cbl-c was enhanced in the presence of Src ( Figure 6A-c, lanes 5 and 6) . It was previously reported that phosphorylation of Cbl at Tyr371 is important for ubiquitin ligase activity (Levkowitz et al., 1999) . We constructed a deletion mutant of Cbl-c, Cbl-c DY341, in which Tyr341 was deleted. This residue corresponds to Tyr371 of Cbl, and deletion of Tyr371 in Cbl abolishes ubiquitin ligase activity. As expected, Cbl-c DY341 showed no ubiquitin ligase activity for Src or itself ( Figure 6A, lane 8) . However, Src phosphorylated both Cbl-c DY341 and wild-type Cbl-c at similar levels, suggesting that Tyr341 of Cbl-c is not phosphorylated at significant levels by Src ( Figure 6A-c, lanes 6 and 8) .
Cbl-c contains the strongest ubiquitin ligase activity for Src
Previous studies showed that Cbl promotes ubiquitination of Src when UbcH7 is present as an E2 (Yokouchi et al., 2001) . However, cooperation of Cbl-c with E2 UbcH7 was absent or much lower in comparison with that with UbcH5C ( Figure 5A ). To address whether each Cbl protein uses distinct E2s, we compared in vitro ubiquitination of Src by Cbl, Cbl-b, and Cbl-c with E2s UbcH5C and GST-UbcH7. Self-ubiquitination of all Cbl family proteins was prominent in the presence of UbcH5C ( Figure 6B-a, lanes 6, 8, and 10) , confirming that UbcH5C is a functional E2 for all Cbl proteins. In contrast, UbcH7 was not active in our system ( Figure  6B-a, lanes 7, 9, and 11) . Moreover, Src was ubiquitinated only in the presence of UbcH5C (Figure 6B-b) . UbcH7 was also inactive in Cbl-and Cbl-b-induced ubiquitination of Src. Consistent with our results, it has been reported that Cbl ubiquitinates EGFR in cooperation with UbcH5B and UbcH5C, but not UbcH7 in vitro (Levkowitz et al., 1999) .
Among Cbl family proteins, Cbl-c showed the strongest ubiquitin ligase activity for Src in vitro ( Figure  6B-b, lanes 6, 8, and 10) , which is consistent with our results in 293T cells ( Figure 4C ). Levels of selfubiquitination and tyrosine phosphorylation were comparable between the different proteins ( Figure 6B -a Figure 5 Cbl-c specifically ubiquitinates Src phosphorylated at Tyr419 in vitro. (A) GST-Cbl-c was incubated with E1, various E2 proteins, and biotinylated ubiquitin. The reaction mixture was subjected to blotting with streptavidin-HRP to detect ubiquitinated proteins. UbcH4, UbcH5A, UbcH5B, and UbcH5C functioned as active E2 for Cbl-c (lanes 7-10). (B) Cbl-c ubiquitinates Src in vitro. The in vitro ubiquitination reaction was performed in the combination of E1, E2 (UbcH5C), GST or GST-Cbl-c as an E3, biotinylated ubiquitin, and wild type or K298M c-Src. GST and GST-Cbl-c were eluted from the glutathione-sepharose. The reaction mixture was probed with anti-Src (a), and streptavidin-HRP (d). The filter used in (a) was reprobed with anti-Tyr419 phosphorylated Src (b), and with anti-Tyr419 nonphosphorylated Src (c). Note that Tyr419 phosphorylated Src, but not nonphosphorylated Src, was specifically ubiquitinated (b and c). Arrowheads indicate the position of Src Cbl-c suppresses v-Src-induced transformation M Kim et al and -c). Self-ubiquitination of Cbl-family proteins was enhanced by Src ( Figure 6B-b) , suggesting that Cblfamily proteins are also degraded in the presence of active Src (Yokouchi et al., 2001) . Consistent with these results, the levels of Cbl-family proteins were decreased by coexpression of Src ( Figure 4C-b) .
Discussion
Here we show that the Cbl-c suppresses v-Src-mediated transformation by degrading v-Src. Cbl-c promotes ubiquitination of activated Src in vivo. Moreover, Cbl-c specifically binds to and ubiquitinates Tyr419-phosphorylated Src in vitro. Our findings suggest that endogenous Cbl-c is a negative regulator of Src. Mutation of the TKB domain of Cbl-c (G298E) completely abolishes the antioncogenic activity against v-Src, whereas mutation of the RING finger (C351A) partially suppresses the antioncogenic activity, suggesting the importance of both domains. Cbl inhibits several tyrosine kinases, including EGFR, PDGFR, and Syk . The TKB domain of Cbl mediates binding to these kinases. We observed that the TKB domain of Cbl-c binds to Src phosphorylated at Tyr419, which is located in the activation loop of the kinase domain. All Src family kinases, except Blk, have the Cbl TKB-binding motif at the autophosphorylation site, suggesting that Cbl-c also suppresses the activity of these kinases. v-Cbl, which has only a TKB domain, binds to activated Src and inhibits the kinase activity . Since Cbl-c C351A also binds Src, the observed partial inhibition of v-Src-mediated transformation by Cbl-c C351A may be due to a conformational interference that inhibits Src kinase activity toward substrates.
The lysosomal inhibitor methylamine blocks Cbl-cinduced degradation of v-Src, indicating that ubiquitination of Src is relevant to its lysosomal degradation. Cbl-mediated ubiquitination of receptor tyrosine kinases serves as a sorting signal for transport to lysosomes (Levkowitz et al., 1998) . Cbl-deficient mice are defective in endocytosis and degradation of pre-T-cell receptor (Panigada et al., 2002) . Degradation of nonreceptor-type tyrosine kinases, such as Hck and Syk, is mediated in part by lysosomes (Paolini et al., 2001; Howlett and Robbins, 2002) . Some population of Src is associated with endosomal membranes and vesicles in 3T3 fibroblasts and PC12 cells (Kaplan et al., 1992) . Another Src-family kinase, Hck, is present in lysosomal vesicles in human macrophages (Astarie-Dequeker et al., 2002) . Although the mechanism of protein trafficking to endosomes by Cbl family members is poorly understood, Cbl forms a complex with CIN85-endophilin to downregulate c-Met and EGF receptors (Petrelli et al., 2002; Soubeyran et al., 2002) . Cbl-c may also act cooperatively with CIN85 to degrade v-Src. It is important to identify adaptors and activators of Cbl-c in endosomal/ lysosomal vesicles.
In this study, we show that the Tyr419 autophosphorylated form of Src is specifically ubiquitinated by Cbl-c. Moreover, Src enhances the ligase activity of Cblc against Src and itself. Therefore, Src activation and Cbl-c-induced ubiquitination of Src are strongly correlated. Phosphorylation is a key component of some ubiquitination pathways (Weissman, 2001) . The mechanism by which Src enhances the ligase activity of Cbl-c must be analysed further to clarify the activity-dependent regulation of Src by Cbl-c.
We showed that Cbl-c has stronger ubiquitin ligase activity against Src than Cbl and Cbl-b both in vitro and in vivo, although all Cbl family proteins induce ubiquitination of Src. This difference may explain our observation that expression of Cbl-c, but not Cbl or Cbl-b, significantly downregulates v-Src, and suppresses the anchorage-independent growth of v-Src-transformed cells. Cbl is reported to ubiquitinate Src, and chicken Src with mutation at Tyr416 to Phe (corresponding to human Src Y419F) is weakly ubiquitinated by Cbl (Yokouchi et al., 2001) . In addition, Src ubiquitination by Cbl requires the RING finger and proline-rich domains, but not the TKB domain of Cbl. Therefore, the mechanism of Src ubiquitination by Cbl-c is different from that by Cbl. Cbl-c is truncated at the carboxy-terminus in comparison with Cbl and Cbl-b. In addition, although the RING finger is conserved in Cbl family proteins (70% homology), the TKB domain of Cbl-c has less homology than those of respectively) . In contrast, the TKB domains of Cbl and Cbl-b have 84% homology. These distinct structural properties of Cbl-c might explain its higher ligase activity against Src. It would be important to compare the three-dimensional structure of Cbl-family proteins.
Expression of Cbl and Cbl-b suppresses the anchorage-independent growth of v-Src-transformed cells, although they cause no significant decrease in the level of v-Src. These results suggest that Cbl and Cbl-b inhibit the signaling molecules downstream of v-Src. We previously identified an adaptor protein, BLNK, as a target of Cbl in B cells (Yasuda et al., 2002) . Cbl-b inhibits signaling mediated by Vav and PI3-K ( Krawczyk et al., 2000) . Identification of critical target proteins for Cbl and Cbl-b in v-Src-transformed cells would clarify the precise roles of Cbl family proteins in tyrosine kinase signaling.
Our present results strongly suggest that endogenous Cbl-c is a negative regulator of Src. Previously, we showed that cbl-c mRNA is expressed at high levels in the colon (Kim et al., 1999) . Deregulated Src kinase activity has been implicated in the progression of colon cancer. Src protein levels are increased modestly in adenomatous polyps and increased further during the progression of colon cancer and metastasis (Irby and Yeatman, 2000) . Therefore, inhibition of Src by Cbl-c could contribute to tumor suppression in these tissues. Abrogation of Cbl-c could result in cancer progression by activating Src, although chromosomal rearrangements or mutations of the CBL-C locus have not been identified. It will be important to establish the role of endogenous Cbl-c in the regulation of tyrosine kinases, including Src, during normal development and in cancer pathology.
Abbreviations SH 2/3, Src homology 2/3; EGFR, epidermal growth factor receptor; PDGER, platelet-derived growth factor receptor; PI3-K, phosphatidylinositol 3-kinase; STAT3, signal transducers and activators of transcription 3; PY, phosphotyrosine.
